Johnson & Johnson (JNJ)
265.88
-2.16
(-0.81%)
USD |
NYSE |
Aug 31, 16:00
266.04
+0.16
(+0.06%)
After-Hours: 20:00
Johnson & Johnson Cash from Operations (TTM) : 27.61B for June 30, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 27.61B |
| March 31, 2026 | 22.87B |
| December 31, 2025 | 24.53B |
| September 30, 2025 | 24.20B |
| June 30, 2025 | 23.03B |
| March 31, 2025 | 24.78B |
| December 31, 2024 | 24.27B |
| September 30, 2024 | 25.15B |
| June 30, 2024 | 24.64B |
| March 31, 2024 | 23.19B |
| December 31, 2023 | 22.79B |
| September 30, 2023 | 20.28B |
| June 30, 2023 | 19.07B |
| March 31, 2023 | 20.47B |
| December 31, 2022 | 21.19B |
| September 30, 2022 | 21.58B |
| June 30, 2022 | 23.58B |
| March 31, 2022 | 23.32B |
| December 31, 2021 | 23.41B |
| September 30, 2021 | 26.02B |
| June 30, 2021 | 26.11B |
| March 31, 2021 | 24.25B |
| December 31, 2020 | 23.54B |
| September 30, 2020 | 21.59B |
| June 30, 2020 | 20.74B |
| Date | Value |
|---|---|
| March 31, 2020 | 23.23B |
| December 31, 2019 | 23.42B |
| September 30, 2019 | 23.26B |
| June 30, 2019 | 22.01B |
| March 31, 2019 | 22.14B |
| December 31, 2018 | 22.20B |
| September 30, 2018 | 22.06B |
| June 30, 2018 | 22.06B |
| March 31, 2018 | 21.75B |
| December 31, 2017 | 21.06B |
| September 30, 2017 | 21.60B |
| June 30, 2017 | 20.70B |
| March 31, 2017 | 19.49B |
| December 31, 2016 | 18.77B |
| September 30, 2016 | 17.20B |
| June 30, 2016 | 17.96B |
| March 31, 2016 | 18.60B |
| December 31, 2015 | 19.28B |
| September 30, 2015 | 18.56B |
| June 30, 2015 | 17.09B |
| March 31, 2015 | 17.42B |
| December 31, 2014 | 18.47B |
| September 30, 2014 | 18.24B |
| June 30, 2014 | 19.54B |
| March 31, 2014 | 19.06B |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| Eli Lilly & Co. | 28.08B |
| Merck & Co., Inc. | 19.97B |
| Pfizer Inc. | 13.40B |
| Bristol Myers Squibb Co. | 12.78B |
| Liquidia Corp. | 167.71M |